Leukocyte common-antigen-related tyrosine phosphatase receptor: Altered expression of mRNA and protein in the New England Deaconess Hospital rat line exhibiting spontaneous pheochromocytoma

Carcinogenesis

Volumn 21, Issue 2, 2000, Pages 125-131

  Yang, Tao ^a   Martignetti, John A ^b   Massa, Stephen M ^a   Longo, Frank M ^a  

^a SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD45 ANTIGEN; MESSENGER RNA; PROTEIN TYROSINE PHOSPHATASE;

ADRENAL MEDULLA; ALTERNATIVE RNA SPLICING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CHROMOSOME 1P; GENE EXPRESSION; GENE MAPPING; HETEROZYGOSITY LOSS; IMMUNOBLOTTING; NONHUMAN; NORTHERN BLOTTING; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE;

EID: 0033984183     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/21.2.125     Document Type: Article

References (44)

1. Hunter, T. (1989) Protein-tyrosine phosphatases: the other side of the coin. Cell, 58, 1013-1016.
2. Zhai, Y.F., Beittenmiller, H., Wang, B., Gould, M.N., Oakley, C., Esselman, W.J. and Welsch, C.W. (1993) Increased expression of specific protein tyrosine phosphatases in human breast epithelial cells neoplastically transformed by the neu oncogene. Cancer Res., 53, 2272-2278.
3. Wiener, J.R., Kerns, B.J., Harvey, E.L., Conaway, M.R., Iglehart, J.D., Berchuck, A. and Bast, R.C.,Jr (1994) Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression. J. Natl Cancer Inst., 86, 372-378.
4. Elson, A. and Leder, P. (1995) Protein-tyrosine phosphatase ε. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras or neu. J. Biol. Chem., 270, 26116-26122.
5. Urushibara, N., Karasaki, H., Nekamura, K., Mizuno, Y., Ogawa, K. and Kikuchi, K. (1998) The selective reduction in PTPdelta expression in hepatomas. Int. J. Oncol., 12, 603-607.
6. Norman, S.A., Golfinos, J.G. and Scheck, A.C. (1998) Expression of a receptor protein tyrosine phosphatase in human glial tumors. J. Neurooncol., 36, 209-217.
7. Brown-Shimer, S., Johnson, K.A., Hill, D.E. and Bruskin, A.M. (1992) Effect of protein tyrosine phosphatase 1B expression on transformation by the human neu oncogene. Cancer Res., 52, 478-482.
8. LaMontagne, K.R., Hannon, G. and Tonks, N.K. (1998) Protein tyrosine phosphatase PTP1B suppresses p210 ber-abl-induced transformation of Rat-1 fibroblasts and promotes differentiation of K562 cells. Proc. Natl Acad. Sci. USA, 95, 14094-14099.
9. Zhai, Y.-F., Wirth, J., Kang, S., Welsch, C.W. and Ezzelman, W.J. (1995) LARPTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells. Mol. Carcinog., 14, 103-110.
10. Keane, M.M., Lowrey, G.A., Ettenberg, S.A., Dayton, M.A. and Lipkowitz, S. (1996) The protein tyrosine phosphatase DEP-I is induced during differentiation and inhibits growth of breast cancer cells. Cancer Res., 56, 4236-4243.
11. Cao, L., Zhang, L., Ruiz-Lozano, P., Yang, Q., Chien, K.R., Graham, R.M. and Zhou, M. (1998) A novel putative protein-tyrosine phosphatase contains a BRO1-like domain and suppresses Ha-ras-mediated transformation. J. Biol. Chem., 273, 21077-21083.
12. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S.I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S.H., Giovanella, B.C., Ittmann, M., Tyeko, B., Hibshoosh, H., Wigler, M.H. and Parsons, R. (1997) PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science, 275, 1943-1947.
13. Liaw, D., Marsh, D.J., Li, J., Dahia, P.L., Wang, S.I., Zheng, Z., Bose, S., Call, K.M., Tsou, H.C., Peacocke, M., Eng, C. and Parsons, R. (1997) Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nature Genet., 16, 64-67.
14. Streuli, M., Krueger, M.X., Hall, L.R., Schlossman, S.F. and Saito, H. (1988) A new member of the immunoglobin superfamily that has the cytoplasmic region homologous to the leukocyte common antigen. J. Exp. Med., 168, 1523-1530.
15. Zhang, J.S. and Longo, F.M. (1995) LAR tyrosine phosphatase receptor: alternative splicing is preferential to the nervous system, coordinated with cell growth and generates novel isoforms containing extensive CAG repeats. J. Cell. Biol., 128, 415-431.
16. Zhang, J.S., Honkaniemi, J., Yang, T. and Longo, F.M. (1998) LAR tyrosine phosphatase receptor: a developmental isoform is present in neurites and growth cones and its expression is regional- and cell-specific. Mol. Cell. Neurosci., 10, 271-286.
17. Honkaniemi, J., Zhang, J.S., Yang, T., Zhang, C., Tisi, M.A. and Longo, F.M. (1998) LAR tyrosine phosphatase receptor: proximal membrane alternative splicing is coordinated with regional expression and intraneuronal localization. Mol. Brain Res., 60, 1-12.
18. O'Grady, P., Thai, T.C. and Saito, H. (1998) The Laminin-nidogen complex is a ligand for a specific splice isoform of the transmembrane protein tyrosine phosphatase. J. Cell Biol., 141, 1675-1684.
19. Yeo, T.T., Yang, T., Massa, S.M., Zhang, J.S., Honkaniemi, J., Butcher, L.L. and Longo, F.M. (1997) Deficient LAR expression decreases basal forebrain cholinergic neuronal size and hippocampal cholinergic innervation. J. Neurosci Res., 47, 348-360.
20. Krueger, M.X., Vactor, D.V., Wan, H.I., Gelbart, W.M., Goodman, C.S. and Saito, H. (1996) The transmembrane tyrosine phosphatase DLAR controls motor axon guidance in Drosophila. Cell, 84, 611-622.
21. Tisi, M.A., Xie, Y., Yeo, T.T. and Longo, F.M. (2000) Downregulation of LAR tyrosine phosphatase prevents apoptosis and augments NGF-induced neurite outgrowth. J. Neurobiol., in press.
22. Genuardi, M., Tsihira, H., Anderson, D.E. and Saunders, G.F. (1989) Distal deletion of chromosome 1p in ductal carcinoma of breast. Am. J. Hum. Genet., 45, 73-82.
23. Ritke, M.K., Shah, R., Valentine, M., Douglass, E.C. and Tereba, A. (1989) Molecular analysis of chromosome 1 abnormalities in neuroblastoma. Cytogenet. Cell Genet., 50, 84-90.
24. Moley, J.F., Brother, M.B., Fong, C.T., White, P.S., Baylin, S.B., Nelkin, B., Wells, S.A. and Brodeur, G.M. (1992) Consistent association of 1p loss of heterozygosity with pheochromocytomas from patient with multiple endocrine type 2 syndromes. Cancer Res., 52, 77-774.
25. Kimmel, D.W., O'Fallon, J.R., Scheithauer, B.W., Kelly, P.J., Dewald, G.W. and Jenkins, R.B. (1992) Prognostic value of cytogenetic analysis in human cerebral astrocytoma. Ann. Neurol., 31, 534-542.
26. Sokova, O.I., Kirichenko, O.P., Mukeria, A.F., Demidov, L.V., Chebotarev, A.N. and Kopnin, B.P. (1992) Enhanced expression of 1p32 and 1p22 fragile sites in lymphocytes in cutaneous malignant melanomas. Cancer Genet Cytogenet., 58, 24-28.
27. Khosla, S., Patel, V.M., Hay, I.D., Schaid, D.J., Grant, C.S., van Heerden, J.A. and Thibodeau, S.N. (1991) Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas. J. Clin. Invest., 87, 1691-1699.
28. Vargas, M.P., Zhuang, Z., Wang, C. Vortmeyer, A., Linehan, W.M. and Merino, M.J. (1997) Loss of heterozygosity on the short arm of chromosomes 1 and 3 in sporadic pheochromocytoma and extra-adrenal paraganglioma. Hum. Pathol., 28, 411-415.
29. Warren, S. and Chute, R.N. (1972) Phaeochromocytoma. Cancer, 29, 327-331.
30. Manger, W.M., Guilford, R.W. and Hoffman, B.B. (1985) Pheochromocytoma: A clinical and experimental overview. Curr. Prob. Cancer IX, 5, 60-69.
31. Gillman, J., Gilbert, C. and Spence, I. (1953) I: Pheochromocytoma in the rat. Cancer, 6, 494-511.
32. Crain, R.C. (1958) Spontaneous tumor in the Rochester strain of the Wistar rat. Am. J. Pathol., 34, 311-335.
33. Poteracki, J. and Walsh, K.M. (1998) Spontaneous neoplasms in control Wistar rats: a comparison of reveiws. Toxicol. Sci., 45, 1-8.
34. Greene, L.A. and Tischler, A.S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl Acad. Sci. USA, 73, 2424-2428.
35. Hoffman, B.B. (1987) Observation in New England Deaconness Hospital rats harboring pheochromocytoma. Clin. Invest. Med., 10, 555-560.
36. Schubert, D., Heinemann, S. and Kidokolo, Y. (1977) Cholinergic metabolism and synapse formation by a rat nerve cell line. Proc. Natl Acad. Sci. USA, 74, 2579-2583.
37. Magal, E., Burnham, P. and Varon, S. (1991) Effect of CNTF on low-affinity NGF receptor expression by cultured neurons from different rat brain regions. J. Neurosci. Res., 30, 560-566.
38. Louis, J.C., Magal, E., Takayama, S. and Varon, S. (1993) CNTF protection of oligodendrocytes against natural and tumor necrosis factor-induced death. Science, 29, 689-692.
39. Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular Cloning: A Laboratory Manual. 2nd edn. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
40. Longo, F.M., Martignetti, J.A., Le Beau, J.M., Zhang, J.S., Barnes, J.P. and Brosius, J. (1993) Leukocyte common antigen-related receptor-linked tyrosine phosphatase. Regulation of mRNA expression. J. Biol. Chem., 268, 26503-26511.
41. Danielson, P.E., Forss-Peter, S., Brow, M.A., Calavelta, L., Douglass, J., Milliner, R.J. and Sutcliffe, J.G. (1988) p1B15: a cDNA clone of the rat mRNA encoding cyclophilin. DNA, 7, 261-267.
42. Foley, K.P., Leonard, M.W. and Engel, J.D. (1993) Quantitation of RNA using the polymerase chain reaction. Trends Genet., 9, 380-385.
43. Jirik, F.R., Harder, K.W., Melhado, I.G., Anderson, L.L. and Duncan, A.M.V. (1992) The gene for LAR is localized to human chromosome 1p32, a region frequently deleted in tumors of neuroectodermal origin. Cytogent. Cell Genet., 61, 266-268.
44. Tischler, A.S., Shih, T.S., Williams, B.O. and Jacks, T. (1995) Characterization of pheochromocytomas in a mouse strain with a targeted disruptive mutation of the neurofibromatosis gene NfI. Endocr. Pathol., 6, 323-355.